Misconceptions about infant vaccinations are commonplace, and information about the best practice for immunizing your child can be very confusing for parents. Experts at the 4th Philips AVENT Breastfeeding & Child Nutrition Conference will be tackling this issue head on, particularly in relation to globalization and the need for an informed decision on how to best protect your child from communicable diseases.

For the 4th year running, Philips AVENT, in corporation with Al Qadi Pharmacy & Est., will host a breastfeeding and early child nutrition forum for both mums, ‘mums-to-be’ and healthcare professionals in the UAE. The conferences will take place in both Abu Dhabi at the Beach Rotana Hotel on 28th May 2012 and in Dubai at its new venue at the Habtoor Grand Hotel on the 30th May 2012.

“The common misconceptions about infant vaccinations tend to relate to autism, neuromuscular disease and cognitive disorders,” says Dr. Wail A. Hayajneh, who is the Chairman and Associate Professor of Pediatric Infectious Diseases at the Jordan University of Science and Technology in Irbid, and a speaker at the Breastfeeding & Child Nutrition conference. “It is important for parents to have a choice when it comes to immunization for their child, but with guidance and awareness.”

Globalization is likely to affect many aspects of public health, one of which is vaccine-preventable communicable diseases. The same applies for children born and reared in the UAE. According to Dr. Wail, some vaccines are traditionally meant for certain areas or certain groups. He says that while this is still valid, globalization has brought people closer to each other, and this has added pressure on pharmaceuticals to come up with solutions (vaccines) that meet the needs of all children. Globalization has also improved life expectancies and induced new needs which bring in the issue of adolescents and adults vaccination.

“For parents living in the UAE, when choosing the right vaccine for your child, factors such as age, geography, demographics, individual issues … all play roles here,” adds Dr. Wail.

For Philips AVENT, their ultimate goal is improving infant and mother’s health. This is why Philips AVENT continues to invest heavily in creating dialog between gynecologists, midwives, breastfeeding advisors, nursing professionals, neonatologists and pediatricians in order to support mothers’ best choices.

“The mission of the Breastfeeding & Child Nutrition Conference is to allow mum’s to make an informed choice when it comes to infant or child nutrition so that they can give their children the best possible start in life,” says Caroline Rainsford, marketing director of Philips Consumer Lifestyle, Middle East and Africa.

During the morning session, mums and ‘mums-to-be’ will be participating in breastfeeding and weaning educational classes. New for this year will be a ‘Meet the Midwife’ initiative where mums and ‘mums-to-be’ will be able to have one-on-one conversations with midwives about any concerns they may have with regards to breastfeeding or child nutrition.

The session for mums and ‘mothers to be’ will start at 8.30am with morning coffee and a complimentary refreshment break will be hosted by Philips AVENT mid-morning. There will also be a crèche and a private breast feeding area.

The afternoon session is aimed at Healthcare Professionals and will start at 1pm with coffee and refreshments followed by presentations on the latest research and developments in breastfeeding and nutrition from across the world.

Along with Dr. Wail, the afternoon session will be chaired by Dr. Mohamad Miqdady who is the Director of Nutrition Services at the Sheikh Khalifa Medical City in Abu Dhabi.  Topics to be discussed include the role of micro-nutrients, the role of globalization and vaccines, as well as a panel session where the audience can ask questions with regards to infant nutrition and local breastfeeding practices.

For more information about attending the ‘free-of-charge’ Philips AVENT Breastfeeding & Child Nutrition Conference please visit www.motherbaby.ae.

About Philips AVENT:

For more information about Philips AVENT, please visit www.avent.com.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity.” Headquartered in the Netherlands, Philips employs about 117,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

For media enquiries please contact:

Inga Stevens

PR & Social Media Manager

T: +971 4 407 2743

F: +971 4 336 4021

inga.stevens@informa.com

Share/Save

Dubai, UAE: The way the healthcare industry accounts for its rising costs is a topic that has received much interest on a global scale. The USA today spends 17-19% of its GDP on healthcare while most countries in the OECD spend 8-9% and the GCC spend 3-4%. In the US, the government sponsored Medicaid and Medicare payment systems are projected to bankrupt the US fiscal system within the next 25-30 years. As the world population swells to just over seven billion, emerging economies along the Silk Road and the aging economies of the Old World alike are facing the similar challenges of treating more people, for more diseases, with dwindling resources.

Dr. Mussaad Al-Razouki, CEO at Kleos Healthcare Corporation in Kuwait, will take part in a plenary session to discuss how higher healthcare costs in the Middle East will affect patient visits to clinics at the upcoming Leaders in Health Conference in Dubai. This topic will be discussed as part of a wider conference program taking place during the 4th Hospital Build & Infrastructure Middle East Exhibition & Congress from 4-6 June 2012.

According to Dr. Al-Razouki, “As Middle East governments pursue ways in which to increase the welfare and citizen’s access to enhanced quality of life measures, increased spending on healthcare is a top priority. The Kuwaiti Ministry of Health recently announced a record budget of US$4 bn for FY 2012-13, which represents a 100% increase from the US$2 bn budget of FY 2007-8 five years ago; this spending accounts for over 80% of the healthcare spending in the country. In Saudi Arabia, the GCC’s largest health care market, the total Saudi healthcare budget (including government and private investment) comes to about US$21.3 bn for the FY 2012-13. In 2007, McKinsey and Co. calculated the GCC‘s expenditure on healthcare to reach a total of $60 billion by 2025; this, however, seems a great underestimation looking at how both the Kuwaiti and Saudi healthcare budgets are increasing.”

Indeed, GCC governments continue to build costly cathedrals of care such as the island hospital of Cleveland Clinic Abu Dhabi and the Sidra Medical Research Center in Qatar. While tertiary centers of excellence with a focus on research are greatly needed in the Middle East, a strong focus also needs to be placed on prevention that reduces the need for hefty investments in healthcare infrastructure. Another large proponent of these exponential MoH budget increases is the increasing dependency on overseas healthcare spending by GCC governments.

“In fact, the generosity of most GCC government’s extends beyond the healthcare of their citizens. Using Kuwait again as example, expatriates are only required to pay a very low yearly assurance premium of US$70 to 180 which pales in comparison to the US$1000-1200 annual cost of their care to the Government of Kuwait. Similar examples can be seen across the GCC, where both nationals and expatriates enjoy significantly subsidized specialty care,” says Dr. Al-Razouki.

Dr. Al-Razouki attributed the underlying issue behind these increase in healthcare costs to the unhealthy lifestyle most people in the Middle East choose to live. He also emphasizes the link between obesity and diabetes type II as it is estimated that these chronically ill diabetes type II patients are four times more likely to be hospitalized, a further cost burden on GCC health budgets.

However, there are reassuring programs across the GCC to help reduce healthcare costs. Certain clinical centers of excellence in Saudi Arabia are piloting an interesting initiative whereby physicians are actually made aware of the costs of procedures and prescriptions before prescribing their treatment to their patients through a computerized physician order entry (CPOE) system that prints out the associated cost of the procedure or prescription.

“This has a dual effect,” explains Dr. Al-Razouki. “Firstly, physicians are less likely to prescribe useless tests and psychological placebo medications, thereby reducing the cost burden on their respective department and secondly, patients who do not even pay a simple co-payment and are used to receiving both the treatment and prescription for free, are made aware of the ‘value’ of the service the Saudi government is providing them. This is an important segue to more accountable care models; other GCC governments should take note.”

Hospital Build & Infrastructure Middle East is the fastest-growing, global business-to-business platform dedicated to bringing together investors, commissioners, backers and managers of healthcare-related building projects with key players in planning, design, construction, operations, management, supply and refurbishment. As investment in the region’s healthcare infrastructure continues to rise, the 2012 event is set to be bigger than ever with more than 130 exhibitors covering 5,000sqm of exhibition floor space, an estimated 4,500 visitors, as well as more than 600 conference delegates.

For more information about the Leaders in Healthcare Conference at Hospital Build 2012, please call +971 (0)4 4072 743 or visit www.hospitalbuild-me.com.

-END-

About Informa Life Sciences:

For more information, please visit www.informalifesciences.com.

About Kleos Healthcare Corporation:

For more information, please visit www.kleoshealth.com.

For media enquiries please contact:

Inga Stevens

PR & Social Media Manager

Informa Life Sciences

T: +971 4 407 2743

F: +971 4 336 4021

inga.stevens@informa.com

Share/Save

Dubai, UAE: Medical mistakes are regrettable but unfortunately they still happen all over the world, including in the UAE. Medical errors can take many forms including delay in implementation of treatment, the lack of due care and neglect. Doctors can be held liable and patients can incur damages as a consequence of criminal, civil and administrative liability laws governing in the UAE.

Dr. Khaldoon Walid Nabhan from the Legal Affairs Department of the Dubai Health Authority (DHA), UAE, will discuss Medical Errors & Liability Law in the UAE at the upcoming Surgery Management Conference in Dubai. This topic will be discussed as part of a wider conference program taking place during the 4th Hospital Build & Infrastructure Middle East Exhibition & Congress from 4-6 June 2012.

According to Dr. Nabhan, “Medical responsibility is influenced by the scientific progress, but it is also significantly influenced by sociological and psychological factors that often are more difficult to analyze. While medical staff and physicians are the ones likely to be held liable when it comes to faulty medical action, it is the patient themselves who could incur physical, financial or moral damage as a result of a medical mistake.  For example, the damage could be the result of incorrect indications given by a pharmacist regarding the use of a drug, or that the damage is incurred by the patient themselves through the non-commitment or non implementation of the correct medical indications.”

The last few years have seen massive investment and expansion in the healthcare industry in the UAE, as is evident from the construction and licensing of various specialized hospitals, clinics, universities and especially the free zones.  This growth has been characterized by the increased role of international healthcare service providers, with the result that increased numbers of international insurers and re-insurers are being exposed to medical malpractice risks in the UAE.

“Medical responsibility in the UAE was formerly defined and governed according to Law 7 of 1975 for the practice of medical professions, which had been a part of civil law,” says Dr. Nabhan. “The passing of Law 10 of 2008, namely the “Law on Medical Responsibility in UAE Nr (10) of 2008 “, created a new framework to deal with this issue.  One of its provisions required medical practitioners to hold insurance policies, so that insurance companies pays damages to the plaintiff (patient) is injured as a result of a physicians’ negligence.  A basic knowledge of the law is required to avoid pitfalls and to safeguard oneself against errors arising from ignorance of the duties and rights of the professional person.”

The Medical Liability Law in the UAE sets out principles to assist in determining whether a practitioner’s conduct amounts to malpractice, negligence or paying insufficient effort creates a framework for medical regulations.

“Should the criminal liability on the part of the physician be established, appropriate punishment should be inflicted,” says Dr. Nabhan. “The new Medical Liability Law imposes several penalties including imprisonment for periods ranging from three months to 10 years and fines ranging from 100,000 to 500,000 dirhams. For example, penalties may be inflicted on a person if they put an end to the life of a patient for whatever reason, undertake human cloning operations, conduct medical research or experiments on humans without license from the competent authorities, implant artificial organs in the patient’s body unless proved suitable, perform Assisted Reproductive Technology or implantation of embryo in the uterus of a woman unless the sperm and egg are taken from a married couple,  and perform any operation or intervention to cause female sterilization unless the pregnancy and delivery constitute certain danger to the woman’s life.”

Hospital Build & Infrastructure Middle East is the fastest-growing, global business-to-business platform dedicated to bringing together investors, commissioners, backers and managers of healthcare-related building projects with key players in planning, design, construction, operations, management, supply and refurbishment. As investment in the region’s healthcare infrastructure continues to rise, the 2012 event is set to be bigger than ever with more than 130 exhibitors covering 5,000sqm of exhibition floor space, an estimated 4,500 visitors, as well as more than 600 conference delegates.

For more information about the Surgery Management Conference at Hospital Build 2012, please call +971 (0)4 4072 743 or visit www.hospitalbuild-me.com.

About Informa Life Sciences:
For more information, please visit www.informalifesciences.com.

About DHA:
For more information, please visit www.dha.gov.ae.

For media inquiries please contact:

Inga Stevens

PR & Social Media Manager
Informa Life Sciences

T: +971 4 407 2743

F: +971 4 336 4021

inga.stevens@informa.com

Share/Save

Dubai, UAE: Informa Life Sciences, organizers of the 4th Hospital Build & Infrastructure Middle East 2012 Exhibition and Congress, has introduced a new category to the upcoming 2012 Hospital Build Awards. The M+Health Award for the Best HealthCare Initiative by a Telecom Provider is aimed at recognizing the use of mobile technologies to improve healthcare initiatives in the Middle East whilst positively impacting the bottom line across the range of stakeholders in the healthcare industry.

For this new awards category, so far more than 25 nominations have been sent in for the consideration of the Hospital Build Awards judging panel. Nominations can be submitted via the website (www.hospitalbuild-me.com) and will close on 3 May 2012.

The Awards also covers six other categories that have received more than 185 nominations, including Best Hospital Design (Built or Future), Best Physical Environment (Built), Best Sustainable Hospital Project, Best Healing Environment, Best Technology Initiative Award and another new category, Best Initiative to Improve the Design Standard of Healthcare Facilities.

The Hospital Build Awards 2012 will recognize leaders in the healthcare industry who have devoted their efforts to building hospitals that help improve healthcare services and raise the bar in providing world-class patient care. They will act as a platform to promote the professionals who have worked hard to achieve a hospital environment that enables and promotes a healthy life.

The Hospital Build Awards winners will be announced on the 4th June at the Hospital Build & Infrastructure Middle East Exhibition and Congress 2012, which will run from 4-6 June 2012, at the Dubai International Convention and Exhibition Center.

The new M+Health Award looks at providers in the Middle East region working to build capacity and implement mobile health (mHealth) solutions that address the global healthcare challenges. mHealth is set to be a booming industry within the healthcare industry especially in the Middle East. Middle Eastern governments are spending vast amounts of money on the construction of healthcare facilities, and these facilities – designed and developed using the latest specifications, designs and IT infrastructure protocols – are ready to adopt mHealth to increase patient care, patient experience and reduce costs.

“With the advancement of technology such as smart phones, computing clouds, voice recognition software, to just name a few, it is only logical to see the market advancement of mHealth solutions,” says Steven A. Matarelli, Chief Operating Office, Administration, Tawam Hospital, Al Ain and member of the Hospital Build Awards judging panel. “Superior healthcare delivery is fundamentally based on information, timing, decision-making, and consumer involvement. Solutions in the arena of mHealth products provide real time experiences that enhance these fundamentals to a great extent.

“Transmission of bio-physiological parameters to care providers in a variety of formats provides access to vital information without the need for actual face-to-face interactivity. This saves time, enhances patient responsibility for their own healthcare, and provides clinicians with information outside the more traditional modes of information gathering. I firmly believe these solutions are gateways to more efficient care delivery, safer patient experiences, and enhanced patient self-efficacy. Above all, eHealth solutions provide access while “on-the-go”, and that is lock-step with our modern lives.”

Simon Page, Managing Director, Informa Life Sciences, the organizer of Hospital Build & Infrastructure Middle East 2012, says: “Research has indicated that the annual consumer market for mobile monitoring devices is projected to increase in 2011 from US$7.7 billion to US$43 billion. Currently, 94% of physicians are using mobile health consulting apps while on the job and 63% of physicians are using personal devices for mobile health solutions that aren’t connected to their practice . The new M+Health Award is in recognition of the importance of this emerging technology in healthcare in the Middle East.”

As investment in the region’s healthcare infrastructure continues to rise, Hospital Build Middle East 2012 is set to be bigger than ever with more than 130 exhibitors covering 5,000sqm of exhibition floor space, an estimated 4,500 visitors, as well as more than 600 conference delegates. Running alongside the exhibition is a multi-disciplinary congress consisting of eight leading conferences that will focus on delivering up-to-date information which will address all the disciplines involved with the hospital build process. New for this year is the inaugural Architect’s Congress.

For more information about 2012 Hospital Build Awards, please call +971 (0)4 4072 743 or visit www.hospitalbuild-me.com.

-END-

Photo caption: Winners of 2011 Hospital Build Awards

Note to Editors

About Informa Life Sciences:
For more information, please visit www.informalifesciences.com.

About Tawam Hospital:
For more information, please visit www.tawamhospital.ae.

For media enquiries please contact:
Inga Stevens
PR & Social Media Manager
Informa Life Sciences
T: +971 4 407 2743

Share/Save

Dubai, UAE: The 2012 Middle East OTO Awards got underway this morning with a prize giving ceremony held on the opening day of the 9th Middle East Update in Otolaryngology Conference & Exhibition (Head and Neck Surgery). The Awards were established to honour otolaryngologists and ENT physicians in the Middle East for their contribution to the field.

The Otolaryngology Conference is produced by Informa Exhibitions and accredited by the Cleveland Clinic. Supported by the UAE Ministry of Health and the Dubai Health Authority, this event is sponsored by Karl Storz, Medtronic, GSK and MSD, and will host more than 120 internally renowned speakers and 600 healthcare professionals who will focus on the most recent advances in ENT disorders such as chronic sinusitis, pediatric otolaryngology, head and neck cancer, cochlear implants and laryngology. The event continues on 23-24 April at the Madinat Jumeirah in Dubai.

At this morning’s Awards ceremony, the Karl Storz Award for Excellence in Teaching was presented to Nabeel Fuleihan from Beirut, Lebanon. The award honours the person who has contributed significantly to the education of ENT physicians in the Middle East. The “Ingeborg and Erwin Hochmair” Award for Service to the Deaf was established in association with MED-EL and, bearing the names of its cofounders, the award honours programmes and physicians who devoted much of their life to the care of the hearing impaired in the Middle East. This award was presented to Dr. Abdulrahman Al Hagr from Riyadh, Saudi Arabia.

The most significant award of the day was the Arab Health Personal and Professional Achievement Award established in association with Arab Health. The Award honours otolaryngologists who have exemplified through their personal life and professional careers deep commitment to the culture and values of the different communities in the Middle East along with determination to further scientific, medical and general development in the region. This year’s Award went to Prof. Akram Hajjar from Damascus, Syria. The Otolaryngology Exhibition showcases the latest technologies and product launches from manufacturers and distributors from the ENT world. This year, Cochlear Ltd, the biggest manufacturer of implantable hearing solutions in the world, has launched its new Arabic-language website at the symposium.

“In a user-friendly, modern website structure, interested parties and parents of children born deaf in all Arabic countries can now easily find their way to a wealth of information about hearing and hearing deficiencies as well as about Cochlear’s hearing solutions and their field of application.” says Mr. Frank Koall, Head of Distributor Operations and Turkey, Cochlear AG, Basel, Switzerland. “The Middle East is one of our most important markets; we have good contacts and relationships to key opinion leaders in this area and hope to deepen the collaboration with them and their clinics at OTO 2012.” Also exhibiting at OTO 2012 are Leader Healthcare, a UAE-based medical equipment marketing and services company, who are showcasing the brand Spiggle & Theis, which has developed a new method for treating Obstructive Eustachian Tube Dysfunction.

According to Shabnam Ansari, Head of Marketing, Leader Healthcare, “So far, the condition has been managed but not treated. The revolutionary procedure is called Balloon Dilation Eustachian Tuboplasty and the method involves a balloon dilatation with a set of especially designed instruments. The procedure is easy, quiet and can be performed with minimal trauma to the patient. Leader Healthcare believes that OTO 2012 is the right platform to launch new and exciting products each year. The event sees participation from luminaries in the field each year, making it a satisfying and successful launch pad for our products.”

The Otolaryngology Conference and Exhibition is open to all trade visitors and healthcare professionals and will continue on 23 & 24 April, from 10am and 6pm. For further information on attending the event, please call +971 (0)4 336 7334 or visit www.me-oto.com.

-END-
Note to Editors

About Informa Exhibitions:
For more information, please visit www.informaexhibitions.com.

About Cochlear Ltd:
For more information, please visit www.cochlear.com.

About Leader Healthcare:
For more information, please visit www.leaderhealthcare.ae.

For media enquiries please contact:
Inga Stevens
PR and Social Media Manager
Life Science Division
Informa Exhibitions
T: +971 4 407 2743
inga.stevens@informa.com

Share/Save

Dubai, UAE: Hearing loss is the third leading chronic disability following arthritis and hypertension in the USA . According to the World Health Organization, over 275 million people globally have moderate-to-profound hearing impairment, 80% of them in low- and middle-income countries. Only limited information is available on developing regions, including Arab countries, where the prevalence is estimated to be markedly higher than in European or North American countries . Some cases of hearing loss can be treated with devices such as hearing aids and Cochlear Implants. However, the production of hearing aids meets less than 10% of global need. In developing countries, fewer than 1 out of 40 people who need a hearing aid have one.

More than 120 experts at the 9th Middle East Update in Otolaryngology Conference & Exhibition (Head and Neck Surgery) taking place on 22-24 April 2012 at the Madinat Jumeirah in Dubai will be discussing the prevalence of hearing impairment and deafness among the Arab populations and assessing the treatment options available for hearing loss, such as Cochlear Implantation.

According to Dr. Susan Waltzman, Co-Director of the NYU Cochlear Implant Center, NYU School of Medicine, NYU Langone Medical Centre, USA, and speakers at the Otolaryngology Conference & Exhibition, the Cochlear Implant is a modern medical marvel: “The majority of adult implant recipients can hear well enough to understand varying degrees of speech, talk on the telephone, be productive professionally, enjoy social interactions and, with some recent developments, even appreciate music. For children who receive cochlear implants at a young age, the auditory and language development benefits can lead to oral communication, language skills often on par with normal hearing peers, attendance in mainstream schools and good self-esteem and social interactions. While it is important to note that about 50% of children born with hearing loss often have additional disabilities, receiving a cochlear implant enables them to achieve their potential.”

Cochlear implant surgery is becoming more common in the region and is being offered in major government and private hospitals.  For example, the American Hospital Dubai is one of the centers of excellence offering audiological, speech and language support, both in English and Arabic.

Not all cases of hearing impairment are treated with Cochlear Implantation as how hearing impairment is treated depends on the underlying cause of the condition. As Dr. Waltzman explains, there are two types of hearing impairment: conductive hearing loss and sensorineural hearing loss, and some people have a combination of the two.

“Conductive hearing loss is caused by dysfunction of the apparatus that transmits sound from the outer ear to the inner ear. Sounds become fainter, as if the ear’s volume has been lowered. These conditions can typically be treated medically or corrected surgically. Hearing aids which amplify sound reaching the inner ear can also help. Sensorineural hearing loss usually stems from damage to the snail-shaped cochlea in the inner ear, particularly its hair cells. Hearing aids can offer benefit to people with mild-to-moderate hearing loss of this type; however, for those with severe-to-profound hearing loss, the best remedy is cochlear implantation,” says Dr. Waltzman.

The Otolaryngology Conference & Exhibition is sponsored by Karl Storz, GSK, Medtronic, MSD, American Hospital Dubai and Amico and will feature 40 exhibiting companies showcasing a range of ENT services and products from the Middle East.

For more information on the Otolaryngology Conference & Exhibition, please call +971 4 407 2743 or visit www.me-oto.com.

-END-
Note to Editors

About Informa Exhibitions:
For more information, please visit www.informaexhibitions.com.

About NYU Langone Medical Centre:
For more information, please visit www.med.nyu.edu.

For media enquiries please contact:
Inga Stevens
PR and Social Media Manager
Life Science Division
Informa Exhibitions
T: +971 4 407 2743
inga.stevens@informa.com

Share/Save

On average women live six to seven years longer than men.  However, the leading causes of death in women such as ischemic heart disease, stroke, lung disease, breast and cervical cancer can be easily prevented through simple screening tests and lifestyle modifications. In the past, work on women’s health was focused on the health problems of women during pregnancy and childbirth. A gender-based approach has broadened our understanding of women’s health problems and helped identify ways to address them for women of all ages.

The Obs-Gyne Exhibition & Congress 2012, organized by Informa Exhibitions in association with Arab Association of Obstetrics and Gynaecology Societies’ (AAOGS), is a platform dedicated to the scientific debate of women’s health in the Middle East.  Taking place at the Dubai International Convention & Exhibition Center, the event will continue tomorrow (3 April) with more than 800 industry professionals returning  for another day of lectures on the latest practices in midwifery, Obstetrics & Gynaecology, women’s healthcare and breast cancer.

For further information, please do not hesitate to contact me on +971 50 684 2682.

You can register on-site from 8:30am – 5pm on 3rd of April 2012.

Kind regards,

Inga Stevens

PR and Social Media Manager

Tel: +971 4 4072743

Fax: +971 4 3364021

inga.stevens@informa.com

www.obs-gyne.com

Share/Save